Selective targeting of cancer cells by copper ionophores: an overview

V Oliveri - Frontiers in molecular biosciences, 2022 - frontiersin.org
Conventional cancer therapies suffer from severe off-target effects because most of them
target critical facets of cells that are generally shared by all rapidly proliferating cells. The …

Copper-induced tumor cell death mechanisms and antitumor theragnostic applications of copper complexes

Y Jiang, Z Huo, X Qi, T Zuo, Z Wu - Nanomedicine, 2022 - Taylor & Francis
Recent studies found that unbalanced copper homeostasis affect tumor growth, causing
irreversible damage. Copper can induce multiple forms of cell death, including apoptosis …

Photothermally triggered copper payload release for cuproptosis‐promoted cancer synergistic therapy

J Zhou, Q Yu, J Song, S Li, XL Li, B Kang… - Angewandte Chemie …, 2023 - Wiley Online Library
Cuproptosis is a new form of programmed cell death and exhibits enormous potential in
cancer treatment. However, reducing the undesirable Cu ion release in normal tissue and …

[HTML][HTML] Biomedical applications of metallic nanoparticles in cancer: Current status and future perspectives

R Khursheed, K Dua, S Vishwas, M Gulati… - Biomedicine & …, 2022 - Elsevier
The current advancements in nanotechnology are as an outcome of the development of
engineered nanoparticles. Various metallic nanoparticles have been extensively explored …

Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicine via cuproptosis

Y Lu, Q Pan, W Gao, Y Pu, B He - Journal of Materials Chemistry B, 2022 - pubs.rsc.org
Platinum-based chemotherapy is widely used to treat various cancers. However, exogenous
platinum is likely to cause severe side effects and drug resistance induced by upregulated …

Metal nanoparticles as a promising technology in targeted cancer treatment

JJ Xu, WC Zhang, YW Guo, XY Chen, YN Zhang - Drug Delivery, 2022 - Taylor & Francis
Traditional anticancer treatments have several limitations, but cancer is still one of the
deadliest diseases. As a result, new anticancer drugs are required for the treatment of …

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Y Lu, Q Pan, W Gao, Y Pu, K Luo, B He, Z Gu - Biomaterials, 2022 - Elsevier
Disulfiram (DSF) has been used as an alcoholism drug for 70 years. Recently, it has
attracted increasing attention owing to the distinguished anticancer activity, which can be …

[HTML][HTML] Cuproptosis: a novel therapeutic target for overcoming cancer drug resistance

Y Wang, Y Chen, J Zhang, Y Yang, JS Fleishman… - Drug Resistance …, 2023 - Elsevier
Cuproptosis is a newly identified form of cell death driven by copper. Recently, the role of
copper and copper triggered cell death in the pathogenesis of cancers have attracted …

Potential of copper and copper compounds for anticancer applications

P Ji, P Wang, H Chen, Y Xu, J Ge, Z Tian, Z Yan - Pharmaceuticals, 2023 - mdpi.com
Inducing cancer cell death has always been a research hotspot in life sciences. With the
continuous deepening and diversification of related research, the potential value of metal …

Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine

X Wang, P Hua, C He, M Chen - Acta Pharmaceutica Sinica B, 2022 - Elsevier
As an emerging cancer therapeutic target, non-apoptotic cell death such as ferroptosis,
necroptosis and pyroptosis, etc., has revealed significant potential in cancer treatment for …